1,712
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis

, , , , , & show all
Pages 589-594 | Received 02 Jul 2017, Accepted 21 Aug 2017, Published online: 03 Sep 2017

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
  • Franko J, Shi Q, Meyers JP, et al. (2016). Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 17:1709–19.
  • Sadeghi B, Arvieux C, Glehen O, et al. (2000). Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–63.
  • Elias D, Gilly F, Boutitie F, et al. (2010). Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–8.
  • Goéré D, Malka D, Tzanis D, et al. (2013). Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257:1065–71.
  • Elias D, Lefevre JH, Chevalier J, et al. (2009). Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–5.
  • Chua TC, Yan TD, Saxena A, et al. (2009). Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249:900–7.
  • Baratti D, Kusamura S, Iusco D, et al. (2014). Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum 57:858–68.
  • Schwegler I, von Holzen A, Gutzwiller J-P, et al. (2009). Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 97:92–7.
  • Ataseven B, du Bois A, Reinthaller A, et al. (2015). Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol 138:560–5.
  • Vugt JLA, van Braam HJ, Oudheusden TR, van, et al. (2015). Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 22:3625–31.
  • Chemama S, Bayar MA, Lanoy E, et al. (2016). Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 23:3891–8.
  • Moon H-G, Ju Y-T, Jeong C-Y, et al. (2008). Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918–22.
  • Okamura A, Watanabe M, Mine S, et al. (2016). Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma. Ann Surg Oncol 23:1387–94.
  • Fujiwara N, Nakagawa H, Kudo Y, et al. (2015). Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–40.
  • CTCAE v4.0 Common Terminology Criteria for Adverse Events (CTCAE) [Internet]; 2010. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
  • Passot G, Vaudoyer D, Villeneuve L, et al. (2017). A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions. Ann Surg 265:806–13.
  • Passot G, Vaudoyer D, Villeneuve L, et al. (2016). What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures: a 25-year wxperience of 1,125 HIPEC. J Surg Oncol 113:796–803.
  • Mohkam K, Passot G, Cotte E, et al. (2016). Resectability of peritoneal carcinomatosis: learnings from a prospective cohort of 533 consecutive patients selected for cytoreductive surgery. Ann Surg Oncol 23:1261–70.
  • Prado CM, Lieffers JR, McCargar LJ, et al. (2008). Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–35.
  • Mourtzakis M, Prado CMM, Lieffers JR, et al. (2008). A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997–1006.
  • Moghadamyeghaneh Z, Hwang G, Hanna MH, et al. (2015). Even modest hypoalbuminemia affects outcomes of colorectal surgery patients. Am J Surg 210:276–84.
  • Garth AK, Newsome CM, Simmance N, et al. (2010). Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer. J Hum Nutr Diet 23:393–401.
  • Reisinger KW, Derikx JPM, van Vugt JLA, et al. (2016). Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer. Clin Nutr 35:924–7.
  • Fearon K, Strasser F, Anker SD, et al. (2011). Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.